Semaille C, Le Strat Y, Chiron E, Chemlal K, Valantin MA, Serre P, et al. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy. Euro Surveillance 2013; 18 (28).
Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377(9769):956–65.
Article
PubMed
Google Scholar
Dolan K, Kite B, Black E, Aceijas C, Stimson GV. HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007;7(1):32–41.
Article
PubMed
Google Scholar
Rotily M, Weilandt C, Bird SM, Kall K, Van Haastrecht HJ, Iandolo E, et al. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Eur J Public Health. 2001;11(3):243–50.
Article
CAS
PubMed
Google Scholar
Marco A, Saiz de la Hoya P, García-Guerrero J, Grupo PREVALHEP. Multi-centre study of the prevalence of infection from HIV and associated factors in Spanish prisons. Rev Esp Sanid Penit. 2012;14(1):19–27.
Article
CAS
PubMed
Google Scholar
Chan S, Marsh K, Lau R, Pakianathan M, Hughes G. An audit of HIV care in English prisons. Int J STD AIDS. 2015;26:504–8.
Article
CAS
PubMed
Google Scholar
Sagnelli E, Starnini G, Sagnelli C, Monarca R, Zumbo G, Pontali E, et al. Blood born viral infections, sexually transmitted diseases and latent tuberculosis in Italian prisons: a preliminary report of a large multicenter study. Eur Rev Med Pharmacol Sci. 2012;16(15):2142–6.
CAS
PubMed
Google Scholar
Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 2013;26(1):10-6. doi: 10.1097/QCO.0b013e32835c1dd0.
Sordo del Castillo L, RuizPérez I, OlryLabry de Lima A, SotoBlanco JM, AntónBasanta JJ, Girela López E, et al. Factors related to refuse antiretroviral therapy in prison. Gac Sanit. 2008;22(2):120–7.
Article
PubMed
Google Scholar
Babudieri S, Starnini G, Brunetti B, Carbonara S, D’Offizi GP, Monarca R, et al. HIV and related infections in Italian penal institutions: epidemiological and health organization note. Annali Istituto Superiore di Sanità. 2003;39(2):251–7.
Google Scholar
Dell’Isola S, Caturelli E, Ialungo A, Rastrelli E, Liguori E, Starnini G. Detention and incompatibility of HIV patients in Italy. Annali Istituto Superiore di Sanità. 2013;49(4):332–3.
Google Scholar
Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep. 2005;2(4):165–70.
Article
PubMed
Google Scholar
Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174(5):721–9.
Article
PubMed Central
PubMed
Google Scholar
Pontali E. Antiretroviral treatment in correctionalfacilities. HIV Clinical Trials. 2005;6(1):25–37.
Article
PubMed
Google Scholar
Zaller N, Thurmond P, Rich JD. Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners. Public Health Rep. 2007;122(1):49–54.
PubMed Central
PubMed
Google Scholar
Springer SA, Friedland GH, Doros G, Pesanti E, Altice FL. Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials. 2007;8(4):205–12.
Article
PubMed Central
PubMed
Google Scholar
Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76:311–7.
Article
CAS
PubMed
Google Scholar
Esposito M. The health of Italian prison inmates today: a critical approach. J Correct Health Care. 2010;16(3):230–8.
Article
PubMed
Google Scholar
Global report: UNAIDS report on the global AIDS epidemic 2012. Available at: http://www.unaids.org/en/resources/campaigns/20121120_globalreport2012/globalreport. Accessed 9 Dec 2015.
Camoni L, Regine V, Stanecki K, Salfa MC, Raimondo M, Suligoi B. Estimates of the number of people living with HIV in Italy. Bio Med Res Int. 2014;2014:209619. doi:10.1155/2014/209619.
Google Scholar
Bollini P, Laporte JD, Harding TW. HIV prevention in prisons. Do international guidelines matter ? Eur J Public Health. 2002;12:83–9.
Article
PubMed
Google Scholar
European Centre for Disease Prevention and Control. Thematic report: Prisoners. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm: ECDC; 2013.
Google Scholar
Dipartimento dell'amministrazione penitenziaria. Ufficio per lo sviluppo e la gestione del sistema informativo automatizzato statistica ed automazione di supporto dipartimentale. Sezione Statistica. Available at: http://www.giustizia.it/giustizia/it/mg_1_14_1.wp?previsiousPage=mg_1_14&contentId=SST1079655. Accessed 9 Dec 2015.
Beckwith C, Bazerman L, Gillani F, Tran L, Larson B, Rivard S, et al. The feasibility of implementing the HIV seek, test, and treat strategy in jails. AIDS Patient Care STDS. 2014;28(4):183–7.
Article
PubMed Central
PubMed
Google Scholar
Shrestha RK, Sansom SL, Richardson-Moore A, French PT, Scalco B, Lalota M, et al. Costs of voluntary rapid HIV testing and counseling in jails in 4 states--advancing HIV Prevention Demonstration Project, 2003-2006. Sex Transm Dis. 2009;36(2):S5-8.
Bauserman RL, Richardson D, Ward M, Shea M, Bowlin C, Tomoyasu N, et al. Increasing voluntary HIV testing by offering oral tests in incarcerated populations. AIDS Educ Prev. 2003;15(5):465–80.
Article
PubMed
Google Scholar
Centers for Disease Control and Prevention. HIV testing implementation guidance for correctional settings. Atlanta: Centers for Disease Control and Prevention; 2009;1-38. http://www.cdc.gov/hiv/topics/testing/resources/guidelines/correctional-settings.
Beckwith CG, Cohen J, Shannon C, Raz L, Rich JD, Lally MA. HIV testing experiences among male and female inmates in Rhode Island. AIDS Read. 2007;17(9):459-64.
Belenko S, Hiller M, Visher C, Copenhaver M, O'Connell D, Burdon W, et al. Policies and practices in the delivery of HIV services in correctional agencies and facilities: results from a multisite survey. J Correct Health Care. 2013;19(4):293–310.
Article
PubMed Central
PubMed
Google Scholar
CDC. HIV testing implementation guidance for correctional settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2009.
Google Scholar
Desai AA, Latt AT, Spaulding A, Rich JD, Flanigan TP. The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev. 2002;14(5 Suppl B):45–52.
Article
PubMed
Google Scholar
Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(1):49–55.
Article
Google Scholar
Lawitz E, Sulkowski MS, Ghalib R, Rodriguez-Torres M, Younossi ZM, Corregidor A, et al. Simeprevir plus sofosbuvir, with orwithout ribavirin, to treat chronic infection with hepatitis C virus genotype 1in non-responders to pegylated interferon and ribavirin and treatment-naïve patients: the COSMOS randomised study. Lancet. 2014;384(9956):1756–65.
Article
CAS
PubMed
Google Scholar
Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, et al. Daclatasvirplus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med. 2014;370(3):211–21.
Article
CAS
PubMed
Google Scholar
Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer K, Shuhart M, et al. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA. 2014;312(4):353–61.
Article
PubMed
Google Scholar
Flanigan TP, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still amissed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55 suppl 2:S78–83.
Article
PubMed
Google Scholar
Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.
Article
PubMed Central
PubMed
Google Scholar
Marco A. Evolution of the prison population mortality after introduction antiretroviraltherapy. Rev Esp Salud Publica. 2011;85(3):233–6.
Article
PubMed
Google Scholar
Solomon L, Montague BT, Beckwith CG, Baillargeon J, Costa M, Dumont D, et al. Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Aff (Millwood). 2014;33(3):434–42.
Article
Google Scholar
Spaulding AC, Booker CA, Freeman SH, Ball SW, Stein MS, Jordan AO, et al. Jails, HIV testing, and linkage to care services: an overview of the EnhanceLink initiative. AIDS Behav. 2013;17(2):S100–7.
Article
PubMed
Google Scholar
Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community—a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2012;33(2):436–44.
Article
PubMed
Google Scholar
Babudieri S, Aceti A, D’Offizi GP, Carbonara S, Starnini G. Directly observed therapy to treat HIV infection in prisoners. JAMA. 2000;284(2):179–80.
Article
CAS
PubMed
Google Scholar
Wohl DA, Stephenson BL, Golin CE, Kiziah CN, Rosen D, Ngo B, et al. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis. 2003;36(12):1572–6.
Article
PubMed
Google Scholar
Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012;89(5):794–801.
Article
PubMed Central
PubMed
Google Scholar
Wohl DA, Cohen C, Gallant JE, Mills A, Sax PE, Dejesus E, et al. A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results. J Acquir Immune Defic Syndr. 2014;65(3):e118–20.
Article
PubMed
Google Scholar
Clumeck N, Molina JM, Henry K, Gathe J, Rockstroh JK, Dejesus E, et al. A Randomized, Double-blind Comparison ofSingle-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vsRitonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF for InitialTreatment of HIV-1 Infection: Analysis of Week 144 Results. J Acquir Immune Defic Syndr. 2014;65(3):e121–4.
Article
PubMed
Google Scholar
Molina JM, Cahn P, Grinsztejn B, Lazzarin A, Mills A, Saag M, et al. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet. 2011;378(9787):238–46.
Article
CAS
PubMed
Google Scholar
Vitoria M, Ford N, Doherty M, Flexner C. Simplification of antiretroviraltherapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings. Antivir Ther. 2014;19(3):31–7.
Article
CAS
PubMed
Google Scholar
Astuti N, Maggiolo F. Single-Tablet Regimens in HIV Therapy. Infect Dis Ther. 2014;3(1):1–17.
Article
PubMed Central
PubMed
Google Scholar
Bangsberg DR, Ragland K, Monk A, Deeks SG. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS. 2010;24(18):2835–40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials. 2002;3:371–8.
Article
PubMed
Google Scholar
Parienti JJ, Bangsberg DR, Verdon R, Gardner EM. Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis. 2009;48(4):484–8.
Article
PubMed Central
PubMed
Google Scholar
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ravlija J, Vasilj I, Marijanović I, Vasilj M. Risk behaviour of prison inmates in relation to HIV/STI. Psychiatr Danub. 2014;26(2):395–401.
PubMed
Google Scholar
Lyons T, Osunkoya E, Anguh I, Adefuye A, Balogun J. HIVprevention and education in state prison systems: an update. J Correct Health Care. 2014;20(2):105–15.
Article
PubMed
Google Scholar
Beckwith C, Bazerman L, Gillani F, Tran L, Larson B, Rivard S, et al. The feasibility of implementing the HIV seek, test, and treat strategy in jails. AIDS Patient Care STDS. 2014;28(4):183–7.
Article
PubMed Central
PubMed
Google Scholar
Farel CE, Parker SD, Muessig KE, Grodensky CA, Jones C, Golin CE, et al. Sexuality, sexual practices and HIV risk among incarcerated African-American women in North Carolina. Womens Health Issues. 2013;23(6):357–64.
Article
Google Scholar
Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison - a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–65.
Article
PubMed Central
CAS
PubMed
Google Scholar
Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lincoln T, Kennedy S, Tuthill R, Roberts C, Conklin TJ, Hammett TM. Facilitators and barriers to continuing healthcare after jail: a community-integrated program. J Ambul Care Manage. 2006;29(1):2–16.
Article
PubMed
Google Scholar
Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9(5):713–9.
PubMed
Google Scholar
Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84–8.
PubMed Central
PubMed
Google Scholar
Nunn A, Cornwall A, Fu J, Bazerman L, Loewenthal H, Beckwith C. Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program. J Urban Health. 2010;87(6):954–68.
Article
PubMed Central
PubMed
Google Scholar
Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep. 2010;125(1):64–71.
PubMed Central
PubMed
Google Scholar